BDRX — BIODEXA PHARMACEUTICALS PLC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 8 SEC-registered investment managers reported holding BDRX (BIODEXA PHARMACEUTICALS PLC) in their latest 13F filings, with a combined reported value of $48.06K across 16.57K shares. That is -85.6% by share count (-95.55K shares) versus the previous quarter, while reported value moved -32.2%. Ownership is concentrated: the five largest holders account for 99.9% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 6 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of BIODEXA PHARMACEUTICALS PLC (BDRX) include SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, HRT FINANCIAL LP, ranked by reported 13F value among the 24 institutional holders on this page.
BDRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 6 | 85.56K | $55.56K | +2961.0% |
| Q2 2026 | 8 | 16.57K | $48.06K | -85.6% |
| Q1 2026 | 8 | 369.10K | $228.07K | +25.3% |
| Q4 2025 | 8 | 305.27K | $692.95K | -52.3% |
| Q3 2025 | 4 | 8.40K | $55.84K | -57.3% |
| Q2 2025 | 4 | 19.67K | $17.01K | -4.4% |
| Q1 2025 | 6 | 21.31K | $28.13K | +165.0% |
| Q4 2024 | 4 | 7.24K | $29.33K | -97.2% |
Over the 8 quarters shown, institutional share counts increased 1081% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+165.0%).
Top Institutional Holders (Q3 2026) — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 71.25K | $46.00K | 0.00% | New | |
| 12.50K | $8.37K | 0.00% | New | |
| 1.79K | $1.17K | 0.00% | Add | |
| 19 | $12 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.81K | $43.09K | 0.00% | Reduce | |
| 1.20K | $3.50K | 0.00% | Reduce | |
| 489 | $1.27K | 0.00% | New | |
| 29 | $84 | 0.00% | Reduce | |
| 25 | $73 | 0.00% | Reduce | |
| 6 | $17 | 0.00% | Reduce | |
| 5 | $15 | 0.00% | Add | |
| 3 | $8 | 0.00% | Reduce |
Q1 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 257.47K | $159.09K | 1.86% | Add | |
| 97.52K | $60.26K | 0.00% | Reduce | |
| 13.78K | $8.52K | 0.00% | Add | |
| 151 | $93 | 0.00% | Add | |
| 127 | $78 | 0.00% | Reduce | |
| 30 | $19 | 0.00% | Hold | |
| 19 | $11 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New |
Q4 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 190.66K | $432.79K | 3.17% | New | |
| 100.00K | $227.00K | 0.00% | New | |
| 10.58K | $24.00K | 0.00% | New | |
| 2.10K | $4.77K | 0.00% | Reduce | |
| 1.78K | $4.03K | 0.00% | Add | |
| 101 | $229 | 0.00% | Reduce | |
| 30 | $68 | 0.00% | New | |
| 24 | $54 | 0.00% | Add |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.92K | $46.05K | 0.00% | Add | |
| 1.35K | $8.99K | 0.00% | Reduce | |
| 115 | $765 | 0.00% | Reduce | |
| 5 | $32 | 0.00% | Reduce |
Q2 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.94K | $10.33K | 0.00% | Add | |
| 5.67K | $4.90K | 0.00% | Add | |
| 1.99K | $1.72K | 0.00% | Reduce | |
| 69 | $59 | 0.00% | Reduce |
New Positions (Q2 2026)
- Allied Private Wealth LLC 489 sh · $1.27K
Fully Exited (vs previous quarter)
- SABBY MANAGEMENT, LLC sold 257.47K sh · $159.09K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 71.25K | — | — | 10.58K | — | — | — | — | — | — | — | — | — | — |
| StoneX Group Inc. | 12.50K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.79K | 25 | 127 | 2.10K | 6.92K | 1.99K | 18.83K | 7.05K | 255.45K | 10.00K | 2.44K | 600 | 71 | — |
| SBI Securities Co., Ltd. | 19 | 29 | 151 | 101 | 115 | 5.67K | 1 | 1 | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 1 | 5 | 1 | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SABBY MANAGEMENT, LLC | — | — | 257.47K | 190.66K | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | 14.81K | 97.52K | 100.00K | — | — | — | — | — | — | — | — | — | — |
| BOOTHBAY FUND MANAGEMENT, LLC | — | — | — | — | — | — | — | — | — | — | — | 44.59K | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | — | — | — | — | — | — | — | 30.11K | — | — | 11.74K | — |
| Virtu Financial LLC | — | — | — | — | — | — | — | — | — | 35.78K | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | 11.70K | — | 53.02K |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | 33.44K | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | — | — | — | — | — | — | 32.58K | 20.56K | — | — | — | — |
| GAMMA Investing LLC | — | 1.20K | 13.78K | 1.78K | 1.35K | 11.94K | 1.43K | — | 287 | 3.89K | 11.10K | 1.04K | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | 859 | 5.24K | 5.24K | — | — |
| Ground Swell Capital, LLC | — | — | — | — | — | — | — | — | — | 13.08K | — | — | — | — |
| Morgan Stanley | — | — | — | — | — | — | 700 | — | 14.32K | 16 | 16 | 16 | 16 | — |
| RHUMBLINE ADVISERS | — | 3 | 19 | 24 | 5 | 69 | 315 | 154 | 6.04K | 2.71K | 498 | 498 | 223 | — |
| Allied Private Wealth LLC | — | 489 | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold BDRX?
As of 2026-Q2, 8 institutional funds reported holding BDRX (BIODEXA PHARMACEUTICALS PLC) in SEC 13F filings, with a combined reported value of $48.06K.
How many shares of BDRX do institutions own?
13F filers reported 16.57K shares of BDRX, worth $48.06K in aggregate at the end of 2026-Q2.
Is institutional ownership of BDRX rising or falling?
Share counts moved -85.6% versus the prior quarter — distribution.
Who are the top institutional holders of BDRX?
The largest 13F holders are SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, HRT FINANCIAL LP, ARMISTICE CAPITAL, LLC, Virtu Financial LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of BIODEXA PHARMACEUTICALS PLC?
The major shareholders of BIODEXA PHARMACEUTICALS PLC (BDRX) by reported 13F value are SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, HRT FINANCIAL LP, ARMISTICE CAPITAL, LLC, Virtu Financial LLC, among 24 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.